Biodesix Inc BDSX Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Nov 10, 2023 (filed on Nov 13, 2023)

Insider Name:

Vazquez Chris

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-108

Price:

$1.23
Nov 10, 2023 (filed on Nov 13, 2023)

Insider Name:

Pestano Gary Anthony

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-218

Price:

$1.23
Nov 10, 2023 (filed on Nov 13, 2023)

Insider Name:

O'Kane Kieran

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-235

Price:

$1.23
Nov 10, 2023 (filed on Nov 13, 2023)

Insider Name:

Hutton Scott

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-1,883

Price:

$1.23
Nov 10, 2023 (filed on Nov 13, 2023)

Insider Name:

Cowie Robin Harper

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-491

Price:

$1.23
Nov 09, 2023 (filed on Nov 13, 2023)

Insider Name:

Vazquez Chris

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-107

Price:

$1.27
Nov 09, 2023 (filed on Nov 13, 2023)

Insider Name:

Pestano Gary Anthony

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-217

Price:

$1.27
Nov 09, 2023 (filed on Nov 13, 2023)

Insider Name:

O'Kane Kieran

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-234

Price:

$1.27
Nov 09, 2023 (filed on Nov 13, 2023)

Insider Name:

Hutton Scott

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-1,882

Price:

$1.27
Nov 09, 2023 (filed on Nov 13, 2023)

Insider Name:

Cowie Robin Harper

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-491

Price:

$1.27

Filings by filing date

Nov 08, 2023 (filed on Nov 13, 2023)

Insider Name:

Vazquez Chris

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-601

Price:

--
Nov 10, 2023 (filed on Nov 13, 2023)

Insider Name:

Vazquez Chris

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-108

Price:

$1.23
Nov 09, 2023 (filed on Nov 13, 2023)

Insider Name:

Vazquez Chris

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-107

Price:

$1.27
Nov 08, 2023 (filed on Nov 13, 2023)

Insider Name:

Vazquez Chris

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

601

Price:

--
Nov 08, 2023 (filed on Nov 13, 2023)

Insider Name:

Pestano Gary Anthony

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-1,378

Price:

--
Nov 10, 2023 (filed on Nov 13, 2023)

Insider Name:

Pestano Gary Anthony

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-218

Price:

$1.23
Nov 09, 2023 (filed on Nov 13, 2023)

Insider Name:

Pestano Gary Anthony

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-217

Price:

$1.27
Nov 08, 2023 (filed on Nov 13, 2023)

Insider Name:

Pestano Gary Anthony

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

1,378

Price:

--
Nov 08, 2023 (filed on Nov 13, 2023)

Insider Name:

O'Kane Kieran

Ownership Type:

Direct Ownership

Securities:

Restricted Stock Units

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-1,489

Price:

--
Nov 10, 2023 (filed on Nov 13, 2023)

Insider Name:

O'Kane Kieran

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-235

Price:

$1.23

News

Biz Brief

Sector: Healthcare	Industry: Healthcare Facilities & Services

See Regulatory Filings on SEC

Company Contact

Address:	Suite 100, 2970 Wilderness Place BOULDER CO 80301
Tel:	1-212-9152568
Website:	https://www.biodesix.com
IR:	See website

Key People

Scott Hutton President, Chief Executive Officer, Director	Robin Harper Cowie Chief Financial Officer, Treasurer, Secretary	Christopher Vazquez Chief Accounting Officer

Business Overview

Biodesix, Inc. (Biodesix) is a data-driven diagnostic solutions company. Biodesix is focused on using technologies with its artificial intelligence platform to discover, develop, and commercialize solutions for clinical unmet needs in lung disease. Biodesix is providing diagnostic testing services associated with blood-based lung tests; coronavirus disease tests and providing biopharmaceutical companies with services that include diagnostic research, clinical research, development, and testing services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics. Its blood-based lung cancer tests include Nodify XL2 and Nodify CDT tests, and GeneStrat and VeriStrat tests. Biodesix also offers SARS-CoV-2 tests under the Biodesix WorkSafe testing program, such as Bio-Rad SARS-CoV-2 ddPCR test, Platelia SARS-CoV-2 Total Ab test and cPass SARS-CoV-2 Neutralizing Antibody testing.

Financial Overview

For the nine months ended 30 September 2023, Biodesix Inc revenues increased 20% to $34.4M. Net loss decreased 5% to $43M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects (Loss) gain on debt extinguishments, net decrease from $3M (expense) to $0K, Research and development - Balancing v decrease of 15% to $7.9M (expense).

Employees:	245 as of Dec 31, 2022

Reporting Currency:	U.S. Dollars
Enterprise value:	$139.97M as of Sep 30, 2023
Annual revenue (TTM):	$44.03M as of Sep 30, 2023
EBITDA (TTM):	-$45.05M as of Sep 30, 2023
Net annual income (TTM):	-$63.35M as of Sep 30, 2023
Free cash flow (TTM):	-$44.58M as of Sep 30, 2023
Net Debt Last Fiscal Year:	$5.16M as of Sep 30, 2023
Shares outstanding:	90,476,295 as of Nov 1, 2023
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization